Company · CIK 2038033
GenEmbryomics Ltd
| CIK | 2038033 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Business address | Australia |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285074 | 2025-02-20 | 2025-04-23 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-23 | RWWithdrawn | 333-285074 | 0001437749-25-012742 |
| 2025-03-28 | EFFECTDeclared effective | 333-285074 | 9999999995-25-000837 |
| 2025-03-25 | F-1/AAmendment | 333-285074 | 0001437749-25-009095 |
| 2025-03-17 | F-1/AAmendment | 333-285074 | 0001437749-25-007827 |
| 2025-02-20 | F-1Registration filed | 333-285074 | 0001437749-25-004473 |
| 2024-09-24 | DRSDraft made public | 377-07458 | 0001437749-24-029885 |